“InspectIR anticipates being able to produce about 100 instruments per week, each of which can be used to evaluate approximately 160 samples per day,” the agency said. “At this level of production, testing capacity using the InspectIR COVID-19 breath analyzer is anticipated to increase by about 64,000 samples per month.”
–
